Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries

BenzingaOct 2 11:10 ET

Gilead Signs Deals With Six Drugmakers for Generic Lenacapavir

Seeking AlphaOct 2 09:47 ET

$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today

BenzingaOct 1 17:34 ET

Incyte Analyst Ratings

BenzingaOct 1 06:05 ET · Ratings

BioNTech's InstaDeep Unit Showcases AI Breakthroughs in Vaccines and Cancer Treatments

BenzingaOct 1 06:04 ET

Optimism Around Aquestive As It Moves Forward With Severe Allergy, Baldness Candidate

BenzingaSep 30 14:25 ET